Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three ...

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

Learn how Aimovig for migraine works, how well it works, what to know before starting, and its possible side effects. Experts and community members also weigh in about their experiences with Aimovig.

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose ...

Zoetis is the undisputed leader in the global animal health industry, and we believe it possesses the widest moat of all the competitors. Zoetis has set itself apart based on its impressive innovation ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

BOSTON, MA / ACCESS Newswire / February 13, 2025 / Medisafe, the leading digital health and patient engagement platform, is proud to announce the launch of PATHWAYS, a new, complimentary tool designed ...

TORONTO - Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has announced the completion of a private placement funding round on February 12, 2025, raising approximately ...

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...

Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.